Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRONCHIOLE
NCT03566667Phase 4Completed
- Start
- Jun 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metoprolol in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Composite measure of all-cause mortality, COPD exacerbations, and cardiovascular events at 1 year. Started Jun 2018; status: completed.
02
Drugs
metoprolol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03566667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566667.